Literature DB >> 23382208

CFTR-deficient pigs display peripheral nervous system defects at birth.

Leah R Reznikov1, Qian Dong, Jeng-Haur Chen, Thomas O Moninger, Jung Min Park, Yuzhou Zhang, Jianyang Du, Michael S Hildebrand, Richard J H Smith, Christoph O Randak, David A Stoltz, Michael J Welsh.   

Abstract

Peripheral nervous system abnormalities, including neuropathy, have been reported in people with cystic fibrosis. These abnormalities have largely been attributed to secondary manifestations of the disease. We tested the hypothesis that disruption of the cystic fibrosis transmembrane conductance regulator (CFTR) gene directly influences nervous system function by studying newborn CFTR(-/-) pigs. We discovered CFTR expression and activity in Schwann cells, and loss of CFTR caused ultrastructural myelin sheath abnormalities similar to those in known neuropathies. Consistent with neuropathic changes, we found increased transcripts for myelin protein zero, a gene that, when mutated, can cause axonal and/or demyelinating neuropathy. In addition, axon density was reduced and conduction velocities of the trigeminal and sciatic nerves were decreased. Moreover, in vivo auditory brainstem evoked potentials revealed delayed conduction of the vestibulocochlear nerve. Our data suggest that loss of CFTR directly alters Schwann cell function and that some nervous system defects in people with cystic fibrosis are likely primary.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23382208      PMCID: PMC3581923          DOI: 10.1073/pnas.1222729110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  57 in total

Review 1.  Submucosal glands and airway defense.

Authors:  Jeffrey J Wine; Nam Soo Joo
Journal:  Proc Am Thorac Soc       Date:  2004

Review 2.  Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients.

Authors:  Naoki Hattori; Masahiko Yamamoto; Tsuyoshi Yoshihara; Haruki Koike; Masanori Nakagawa; Hiroo Yoshikawa; Akio Ohnishi; Kiyoshi Hayasaka; Osamu Onodera; Masayuki Baba; Hitoshi Yasuda; Toyokazu Saito; Kenji Nakashima; Jun-ichi Kira; Ryuji Kaji; Nobuyuki Oka; Gen Sobue
Journal:  Brain       Date:  2003-01       Impact factor: 13.501

3.  Alterations of annexin expression in pathological neuronal and glial reactions. Immunohistochemical localization of annexins I, II (p36 and p11 subunits), IV, and VI in the human hippocampus.

Authors:  D A Eberhard; M D Brown; S R VandenBerg
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

4.  Autonomic nervous system abnormalities in cystic fibrosis.

Authors:  P B Davis; M Kaliner
Journal:  J Chronic Dis       Date:  1983

5.  Abnormal adrenergic and cholinergic sensitivity in cystic fibrosis.

Authors:  P B Davis; J R Shelhamer; M Kaliner
Journal:  N Engl J Med       Date:  1980-06-26       Impact factor: 91.245

6.  Uncoupling of myelin assembly and schwann cell differentiation by transgenic overexpression of peripheral myelin protein 22.

Authors:  S Niemann; M W Sereda; U Suter; I R Griffiths; K A Nave
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

7.  Calnexin deficiency leads to dysmyelination.

Authors:  Allison Kraus; Jody Groenendyk; Karen Bedard; Troy A Baldwin; Karl-Heinz Krause; Michel Dubois-Dauphin; Jason Dyck; Erica E Rosenbaum; Lawrence Korngut; Nansi J Colley; Simon Gosgnach; Douglas Zochodne; Kathryn Todd; Luis B Agellon; Marek Michalak
Journal:  J Biol Chem       Date:  2010-04-16       Impact factor: 5.157

8.  An axonal form of Charcot-Marie-Tooth disease showing distinctive features in association with mutations in the peripheral myelin protein zero gene (Thr124Met or Asp75Val).

Authors:  K Misu; T Yoshihara; Y Shikama; E Awaki; M Yamamoto; N Hattori; M Hirayama; T Takegami; K Nakashima; G Sobue
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-12       Impact factor: 10.154

9.  Cystic fibrosis transmembrane conductance regulator expression in human spinal and sympathetic ganglia.

Authors:  Na Niu; Jie Zhang; Yong Guo; Chunzhang Yang; Jiang Gu
Journal:  Lab Invest       Date:  2009-03-30       Impact factor: 5.662

10.  Intermediate Charcot-Marie-Tooth disease due to a novel Trp101Stop myelin protein zero mutation associated with debilitating neuropathic pain.

Authors:  Juan D Ramirez; Phillip R J Barnes; Kerry R Mills; David L H Bennett
Journal:  Pain       Date:  2012-06-16       Impact factor: 6.961

View more
  24 in total

Review 1.  Genome editing revolutionize the creation of genetically modified pigs for modeling human diseases.

Authors:  Jing Yao; Jiaojiao Huang; Jianguo Zhao
Journal:  Hum Genet       Date:  2016-07-18       Impact factor: 4.132

2.  Sex-specific airway hyperreactivity and sex-specific transcriptome remodeling in neonatal piglets challenged with intra-airway acid.

Authors:  Leah R Reznikov; Yan Shin J Liao; Tongjun Gu; Katelyn M Davis; Shin Ping Kuan; Kalina R Atanasova; Joshua S Dadural; Emily N Collins; Maria V Guevara; Kevin Vogt
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-11-08       Impact factor: 5.464

3.  Development of a polarized pancreatic ductular cell epithelium for physiological studies.

Authors:  Yunxia O'Malley; Pavana G Rotti; Ian M Thornell; Oriana G Vanegas Calderón; Christopher Febres-Aldana; Katelin Durham; Jianrong Yao; Xiaopeng Li; Zheng Zhu; Andrew W Norris; Joseph Zabner; John F Engelhardt; Aliye Uc
Journal:  J Appl Physiol (1985)       Date:  2018-03-08

Review 4.  Cystic Fibrosis and the Nervous System.

Authors:  Leah R Reznikov
Journal:  Chest       Date:  2016-11-19       Impact factor: 9.410

5.  A role for the cystic fibrosis transmembrane conductance regulator in the nitric oxide-dependent release of Cl- from acidic organelles in amacrine cells.

Authors:  Vijai Krishnan; J Wesley Maddox; Tyler Rodriguez; Evanna Gleason
Journal:  J Neurophysiol       Date:  2017-08-23       Impact factor: 2.714

6.  Acute administration of ivacaftor to people with cystic fibrosis and a G551D-CFTR mutation reveals smooth muscle abnormalities.

Authors:  Ryan J Adam; Katherine B Hisert; Jonathan D Dodd; Brenda Grogan; Janice L Launspach; Janel K Barnes; Charles G Gallagher; Jered P Sieren; Thomas J Gross; Anthony J Fischer; Joseph E Cavanaugh; Eric A Hoffman; Pradeep K Singh; Michael J Welsh; Edward F McKone; David A Stoltz
Journal:  JCI Insight       Date:  2016-04-07

Review 7.  Genetically modified pigs to model human diseases.

Authors:  Tatiana Flisikowska; Alexander Kind; Angelika Schnieke
Journal:  J Appl Genet       Date:  2014-02       Impact factor: 3.240

Review 8.  Lessons learned from the cystic fibrosis pig.

Authors:  David K Meyerholz
Journal:  Theriogenology       Date:  2016-04-21       Impact factor: 2.740

9.  Solitary Cholinergic Stimulation Induces Airway Hyperreactivity and Transcription of Distinct Pro-inflammatory Pathways.

Authors:  Leah R Reznikov; David K Meyerholz; Shin-Ping Kuan; Maria V Guevara; Kalina R Atanasova; Mahmoud H Abou Alaiwa
Journal:  Lung       Date:  2018-01-29       Impact factor: 2.584

10.  Air trapping and airflow obstruction in newborn cystic fibrosis piglets.

Authors:  Ryan J Adam; Andrew S Michalski; Christian Bauer; Mahmoud H Abou Alaiwa; Thomas J Gross; Maged S Awadalla; Drake C Bouzek; Nicholas D Gansemer; Peter J Taft; Mark J Hoegger; Amit Diwakar; Matthias Ochs; Joseph M Reinhardt; Eric A Hoffman; Reinhard R Beichel; David K Meyerholz; David A Stoltz
Journal:  Am J Respir Crit Care Med       Date:  2013-12-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.